Clyde Yancy, MD, vice dean for diversity and inclusion, chief of cardiology, and a professor of medicine in cardiology and medical social sciences at Northwestern Medicine, discusses health equity issues and how greater inclusion should be a business model because of changing demographics.

A diabetes treatment drug, Mounjaro, has been added to the Food and Drug Administration’s (FDA) list of drug shortages.

The AHA Mission: Lifeline Program was designed to reduce STEMI patient transfer times, but response times still often lag, and new protocols may be needed to expedite STAT transfers.

FDA Commissioner Robert Califf, MD, who is a cardiologist, spoke at the opening session of the American Heart Association about the need to step up and address two major problems in the American healthcare system. 

U.S. physicians might be missing out on innovative medical research due to the overwhelming amount of reading and clinical work they are faced with, according to a recent survey.

Contrary to older research that showed neuroimaging emerging as the single most dominating cost contributor in ischemic stroke care for older Americans, a new study shows treatment and other line items account for bigger slices of the bill.

A new policy statement from the American College of Cardiology highlights the importance of career flexibility—including the ability to change hours or work responsibilities when necessary—for cardiologists of all ages. 

Three medical journals are investigating possible manipulation of data in heart studies led by researchers from Temple University that found favorable health impacts of blood thinners.